News Release
June 13,2023
Announcement of Newly Developed Compound for Antibody-Inducing Peptide against Pollinosis [PDF file]
May 16,2023
May 16,2023
February 14,2023
December 22,2022
May 16,2023
May 16,2023
December 22,2022
September 14,2022
Notice of participation in “the 2022 NEDO Silicon Valley Pitch Night”
December 25,2020
Announcement of New Listing on Tokyo Stock Exchange’s Mothers [PDF file]
June 13,2023
Announcement of Newly Developed Compound for Antibody-Inducing Peptide against Pollinosis [PDF file]
February 14,2023
November 22,2022
October 17,2022
Notice of Business Transfer to Consolidated Subsidiary [PDF file]
August 18,2022
Exercise of Option by MEDIPAL HOLDINGS CORPORATION [PDF file]
Peptide is the general term for a compound that is made of 2 to 50 amino acids linked together. A compound of further more amino acids linked together is called protein, and the major part of a human body consists of proteins. Inside peptide are hormones such as insulin, glucagon, calcitonin, which are substances in charge of the information transfer that regulates functioning of internal organs. Using functions of the said peptide, we create pharmaceutical products called peptide-based medicines.
Our Services
more details
more details
more details
more details
more details
more details
more details
Nihonbashi Life Science Building2 No.503, 3-11-5 Nihonbashi-honcho, Chuo-ku, Tokyo 103-0023
2-minute walk from Shin-Nihombashi Station on the JR Sobu Rapid Line.
3-minute walk from Kodemmacho Station on the Tokyo Metro Hibiya Line.